A Clinical Trial Aimed at Assessing the Efficacy and Safety of VT-101 for the Treatment of Non-muscle Invasive Bladder Cancer

NCT06632964 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Non-muscle Invasive Bladder Cancer

Interventions

BIOLOGICAL: Recombinant oncolytic adenovirus injection solution of VT-101

Sponsor

The Affiliated Hospital of Xuzhou Medical University

Collaborators

[object Object]